Atlas Trials

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Clinical trial NCT00005857 · COMPLETED

Trial details

NCT number
NCT00005857
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2000-08-01
Primary completion
2002-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.